Interestingly 3 of the 4 cases in HCNG cohort were inflammatory breast carcinomas (1 ER−/PR−/HER2− and 2 ER+/PR−/HER2−; range 6–13 % of tumor cells). The gene discussed is ESR1; the disease is neoplasm.